Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pupillary Unrest and Opioid-Induced Respiratory Depression
NCT04301895Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Impact of environmental stimulation on decline in oxygen saturation to ≤ 90% at 35 months, Impact of environmental stimulation on CO2 increase of 15% or more above baseline at 35 months and 1 more. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT04301895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04301895.